MAOA and neoplasm: In our study, we found that MAOI treatment synergised with anti-PD-1 treatment in suppressing syngeneic mouse tumor growth (Fig. 5k–o), and that intratumoral MAOA gene expression levels dictated poor patient survival in melanoma patients receiving anti-PD-1 therapy (Fig. 6r).